Nele Myngheer

The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial.

E. Dirinck, C. D. De Block, B. Keymeulen, 2022, Journal of diabetes science and technology.

Fetal Macrosomia and Neonatal Hyperinsulinemic Hypoglycemia Associated With Transplacental Transfer of Sulfonylurea in a Mother With KCNJ11-Related Neonatal Diabetes

F. Ashcroft, A. Hattersley, C. Mathieu, 2014, Diabetes Care.

Mobile-Based Lifestyle Intervention in Women with Glucose Intolerance after Gestational Diabetes Mellitus (MELINDA), A Multicenter Randomized Controlled Trial: Methodology and Design

C. Mathieu, A. Bogaerts, C. Matthys, 2020, Journal of clinical medicine.

Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial.

E. Dirinck, C. D. De Block, B. Keymeulen, 2023, The lancet. Diabetes & endocrinology.

Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial

C. Mathieu, E. Dirinck, S. Fieuws, 2021, The Lancet.

Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1)

E. Dirinck, B. Keymeulen, P. Gillard, 2022 .

Impact of breastfeeding on risk of glucose intolerance in early postpartum after gestational diabetes

J. Verhaeghe, A. Laenen, K. Benhalima, 2024, Frontiers in endocrinology.